CN114946984A - Oral myocardial peptide and neurotonin combined tablet candy and preparation method thereof - Google Patents
Oral myocardial peptide and neurotonin combined tablet candy and preparation method thereof Download PDFInfo
- Publication number
- CN114946984A CN114946984A CN202110213348.9A CN202110213348A CN114946984A CN 114946984 A CN114946984 A CN 114946984A CN 202110213348 A CN202110213348 A CN 202110213348A CN 114946984 A CN114946984 A CN 114946984A
- Authority
- CN
- China
- Prior art keywords
- powder
- neurotonin
- oral
- truffle
- myocardial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002107 myocardial effect Effects 0.000 title claims abstract description 13
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 37
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 8
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 8
- 241000234435 Lilium Species 0.000 claims abstract description 7
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 7
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 7
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 6
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims abstract description 6
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000609666 Tuber aestivum Species 0.000 claims abstract description 6
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000013305 food Nutrition 0.000 claims abstract description 6
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 6
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 6
- 229960002675 xylitol Drugs 0.000 claims abstract description 6
- 235000010447 xylitol Nutrition 0.000 claims abstract description 6
- 239000000811 xylitol Substances 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 4
- 241000724115 Ziziphus lotus Species 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 240000008866 Ziziphus nummularia Species 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 235000011201 Ginkgo Nutrition 0.000 claims description 3
- 244000194101 Ginkgo biloba Species 0.000 claims description 3
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 3
- 244000223977 Tuber melanosporum Species 0.000 claims description 3
- 235000002777 Tuber melanosporum Nutrition 0.000 claims description 3
- 235000005638 Austrian pine Nutrition 0.000 claims description 2
- 235000008565 Pinus banksiana Nutrition 0.000 claims description 2
- 244000019397 Pinus jeffreyi Species 0.000 claims description 2
- 235000013264 Pinus jeffreyi Nutrition 0.000 claims description 2
- 235000008578 Pinus strobus Nutrition 0.000 claims description 2
- 235000008585 Pinus thunbergii Nutrition 0.000 claims description 2
- 235000014030 Podocarpus spicatus Nutrition 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 235000002378 plant sterols Nutrition 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims description 2
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 claims description 2
- 239000007779 soft material Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims 3
- 108010087806 Carnosine Proteins 0.000 claims 3
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims 3
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims 3
- 229940044199 carnosine Drugs 0.000 claims 3
- 238000000034 method Methods 0.000 claims 1
- 230000000149 penetrating effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 210000003792 cranial nerve Anatomy 0.000 abstract 2
- 230000006870 function Effects 0.000 abstract 2
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 230000008828 contractile function Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 230000002526 effect on cardiovascular system Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 208000026106 cerebrovascular disease Diseases 0.000 description 6
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical group CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 5
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 5
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 241000572565 Alpinia oxyphylla Species 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000003925 brain function Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004149 ethanol metabolism Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention relates to an oral myocardial peptide and neurotonin combined tablet candy and a preparation method thereof. The food is prepared from various food materials such as gamma-aminobutyric acid, phosphatidylserine, truffle powder (truffle), fructus alpiniae oxyphyllae powder, lily powder, lotus seed powder, yam powder, spina date seed powder, white fruit powder, phytosterol, earthworm protein and xylitol. Is an oral myocardial peptide and neurotonin combined tablet candy, which is just like a 'hospital' in the body, and can recover diseases by activating myocardial cells, enhancing the cardiac contractile function, repairing damaged cranial nerves and maintaining the normal function of the cranial nerves. Has the function of protecting the heart.
Description
One, the technical field
The invention relates to the field of nutritional foods, in particular to an oral myocardial peptide and neurotonin combined tablet candy.
Second, background Art
Cardiovascular and cerebrovascular health is one of the topics with higher social attention, cardiovascular and cerebrovascular diseases threaten the life health of every person, the cardiovascular and cerebrovascular diseases are called as one of ten invisible killers of the 21 st century, the harm of the cardiovascular and cerebrovascular diseases can be seen, and particularly, in recent years, the improvement of living standard and the increase of competitive pressure make the cardiovascular and cerebrovascular diseases have a good opportunity. According to incomplete statistics, the number of deaths due to cardiovascular and cerebrovascular diseases reaches millions every year. Therefore, a fresh life is behind the huge numbers heard by a hacker, so that the hacker is indiscriminately deprived of cardiovascular and cerebrovascular diseases, and after the hacker feels painful, the exclamation is fragile, and simultaneously, the heart and the cerebral vessels are prevented from being extremely urgent.
Third, the invention
The most important nerve of human brain, the most important nutrient component of nerve is nervonic acid, only nervonic acid can repair nerve cells, the myocardial peptide activates necrotic damaged myocardial cells to help the myocardial cells to generate antibodies, so that the myocardial cells can recover the activity and recover the normal myocardial function, the product is jointly developed by Shaanxi Luomandan medicine Limited company and Xianhuasen medicine bioengineering Limited company, the product is based on the nervonic acid extracted from plants and the myocardial peptide extracted from earthworm protein, the product has strong research and development team support, the international advanced extraction and production technology is introduced, and the product is refined through ten-year worries. The product overcomes the limitation of the single prescription with the compound prescription, and the effect of the compound prescription is superior to that of the single prescription! Specially, aiming at the aging of middle-aged and old people and more than 40 chronic diseases, on the basis of nervonic acid, more than ten traditional Chinese medicine components which are good for heart and brain, such as sharpleaf galangal fruit, lily, lotus seed and the like, are added, so that the compound nervonic acid health-care product is more perfect.
After a plurality of experiments and the consumption of food materials is controlled, an oral myocardial peptide and neurotonin combined tablet candy is researched. The invention is elaborately developed by various food materials such as gamma-aminobutyric acid, phosphatidylserine, black pine dew powder (truffle), fructus alpiniae oxyphyllae powder, lily powder, lotus seed powder, yam powder, spina date seed powder, white fruit powder, phytosterol, earthworm protein and xylitol. The gamma-aminobutyric acid has the effects of tranquilizing nerves, reducing blood pressure, treating diseases, reducing blood ammonia, improving brain activity, promoting ethanol metabolism and preventing arteriosclerosis; the phosphatidylserine has the effects of improving brain functions, concentrating attention, improving memory, relieving pressure, promoting recovery of brain fatigue, balancing emotion and helping to repair brain injury; the black truffle has the effects of regulating endocrine, preventing senile dementia, resisting fatigue, resisting tumor and preventing atheroma; fructus Alpinae Oxyphyllae has effects of warming spleen, relieving diarrhea, warming kidney, arresting polyuria, and stopping nocturnal emission, and can be used for treating deficiency cold of spleen and stomach, emesis, diarrhea, abdominal psychroalgia, excessive saliva, renal deficiency, enuresis, pollakisuria, nocturnal emission, and whitish and turbid urine; the lily has the effects of moistening lung, relieving cough, clearing away heart-fire and tranquilizing; the lotus seed has the effects of tonifying spleen, stopping diarrhea, stopping leukorrhagia, tonifying kidney, arresting seminal emission, nourishing heart and soothing nerves. The book of Li Shizhen, Ben Cao gang mu, calls that the lotus seed tonifies the middle-jiao and nourishes the mind, supplements qi, takes the body gently, resists aging, does not allay hunger and prolongs the life, benefits heart and kidney, strengthens essence and qi, strengthens bones and muscles, tonifies deficiency and benefits ears and eyes; the yam has the effects of tonifying spleen and stomach, helping digestion, nourishing kidney and essence, benefiting lung and relieving cough, reducing blood sugar and prolonging life; the wild jujube can 'calm five internal organs, lighten body and prolong life'. The wild jujube has great medicinal value and can play the roles of nourishing the liver, calming the heart, soothing the nerves and arresting sweating. It is often used in medicine to treat neurasthenia, vexation, insomnia, dreaminess, night sweat, and convulsion. Meanwhile, a certain nourishing and strengthening effect can be achieved; the ginkgo has the effects of dredging blood vessels, protecting liver, improving brain function, moistening skin, resisting aging and treating senile dementia and cerebral ischemia; the phytosterol has anti-inflammatory effect, and has effects of preventing coronary atherosclerosis and reducing cholesterol; the earthworm protein has the effects of improving microcirculation, dissolving thrombus, softening blood vessels, reducing blood viscosity, regulating blood pressure and reducing blood sugar; xylitol has effects of improving liver function and stabilizing insulin.
In order to ensure that the absorption of effective components by human body reaches the maximum, the tabletting candy is finally selected through a plurality of tests, so that the absorption by human body is more convenient.
Fourth, detailed description of the invention
The preparation process of the invention is as follows:
firstly, taking the material fine powder with the formula amount, fully stirring and uniformly mixing for later use;
secondly, adding a proper amount of purified water into a mixer, stirring and mixing uniformly to prepare a soft material, granulating by using a 18-mesh sieve, drying at 50 ℃, grading dry granules by using a 16-mesh sieve, and collecting qualified granules for later use; dry pellet moisture controlled to within 6%;
and thirdly, adding the qualified granules into a charging basket of a tablet press, tabletting, coating a transparent film coat and subpackaging to obtain the finished product.
The specific formulation is shown in the following table:
| composition (I) | Content (kg) |
| Gamma-aminobutyric acid | 12 |
| Phosphatidylserine | 18 |
| Black truffle powder (truffle) | 8.4 |
| Intelligence-benefiting kernel powder | 3.6 |
| Lily powder | 9.6 |
| Lotus seed powder | 9.6 |
| Yam powder | 9.6 |
| Wild jujube kernel powder | 3.6 |
| Ginkgo powder | 3.6 |
| Plant sterol | 18 |
| Earthworm protein | 18 |
| Xylitol, its preparation method and use | 6 |
Claims (4)
1. An oral myocardial peptide and neurotonin combined tabletting candy is characterized by being prepared from a plurality of food materials of gamma-aminobutyric acid, phosphatidylserine, black pine dew powder (truffle), fructus alpiniae oxyphyllae powder, lily powder, lotus seed powder, yam powder, spina date seed powder, white fruit powder, phytosterol, earthworm protein and xylitol.
2. An oral carnosine and neurotonin combination tabletted confectionery according to claim 1, wherein the tabletted confectionery is selected to be one that is capable of rapidly penetrating tissue cells to act after multiple trials.
3. An oral carnosine and neurotonin-conjugated tabletted candy according to claim 1, prepared by the process comprising:
firstly, taking the material fine powder with the formula amount, fully stirring and uniformly mixing for later use;
secondly, adding a proper amount of purified water into a mixer, stirring and mixing uniformly to prepare a soft material, granulating by using a 18-mesh sieve, drying at 50 ℃, grading dry granules by using a 16-mesh sieve, and collecting qualified granules for later use; [ dry granule moisture control within 6%);
and thirdly, adding the qualified granules into a material barrel of a tablet press, tabletting, coating a transparent film coat and subpackaging to obtain the tablet.
4. The oral carnosine and neurotonin-conjugated tabletted candy according to claim 1, wherein the formulation is as follows:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110213348.9A CN114946984A (en) | 2021-02-25 | 2021-02-25 | Oral myocardial peptide and neurotonin combined tablet candy and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110213348.9A CN114946984A (en) | 2021-02-25 | 2021-02-25 | Oral myocardial peptide and neurotonin combined tablet candy and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114946984A true CN114946984A (en) | 2022-08-30 |
Family
ID=82974247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110213348.9A Pending CN114946984A (en) | 2021-02-25 | 2021-02-25 | Oral myocardial peptide and neurotonin combined tablet candy and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114946984A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658233A (en) * | 2009-09-07 | 2010-03-03 | 汕头市新特医药有限公司 | Tablet candy and producing method thereof |
| CN105166295A (en) * | 2015-10-08 | 2015-12-23 | 广州市炜鑫生物科技有限公司 | Pressed candy rich in gamma-aminobutyric acid and cordyceps militaris and preparation method of pressed candy |
| CN105994919A (en) * | 2016-06-29 | 2016-10-12 | 山东润美生物科技有限公司 | Phosphatidylserine fructus alpiniae oxyphyllae tableted candy |
| CN106376698A (en) * | 2016-02-03 | 2017-02-08 | 广州市炜鑫生物科技有限公司 | Compressed tablet candy rich in phytosterol and preparation method thereof |
| CN109043098A (en) * | 2018-07-24 | 2018-12-21 | 天津民生生物工程股份有限公司 | One kind edible ground dragon protein pressed candy and its processing technology |
| CN109511766A (en) * | 2017-09-20 | 2019-03-26 | 于东洋 | A kind of preparation method and application of Ou Liguo calcium pressed candy |
| CN109997946A (en) * | 2019-02-20 | 2019-07-12 | 山东佰诺生物科技有限公司 | A kind of compound pressed candy and preparation method thereof |
-
2021
- 2021-02-25 CN CN202110213348.9A patent/CN114946984A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101658233A (en) * | 2009-09-07 | 2010-03-03 | 汕头市新特医药有限公司 | Tablet candy and producing method thereof |
| CN105166295A (en) * | 2015-10-08 | 2015-12-23 | 广州市炜鑫生物科技有限公司 | Pressed candy rich in gamma-aminobutyric acid and cordyceps militaris and preparation method of pressed candy |
| CN106376698A (en) * | 2016-02-03 | 2017-02-08 | 广州市炜鑫生物科技有限公司 | Compressed tablet candy rich in phytosterol and preparation method thereof |
| CN105994919A (en) * | 2016-06-29 | 2016-10-12 | 山东润美生物科技有限公司 | Phosphatidylserine fructus alpiniae oxyphyllae tableted candy |
| CN109511766A (en) * | 2017-09-20 | 2019-03-26 | 于东洋 | A kind of preparation method and application of Ou Liguo calcium pressed candy |
| CN109043098A (en) * | 2018-07-24 | 2018-12-21 | 天津民生生物工程股份有限公司 | One kind edible ground dragon protein pressed candy and its processing technology |
| CN109997946A (en) * | 2019-02-20 | 2019-07-12 | 山东佰诺生物科技有限公司 | A kind of compound pressed candy and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20190328817A1 (en) | Traditional chinese medicine healthcare preparation for fat elimination and weight reduction | |
| CN104305207A (en) | Formula of traditional Chinese medicine composite ferment and preparing method thereof | |
| AU2016201968A1 (en) | Sporoderm-broken ganoderma lucidum spore powder, honey & propolis buccal tablet and manufacturing method thereof | |
| CN105010891A (en) | Chicken feed containing Chinese herbal medicine additive | |
| CN112791175A (en) | Chinese and western medicine composition for improving human body metabolism function and discharging metabolic waste and preparation method thereof | |
| CN114946984A (en) | Oral myocardial peptide and neurotonin combined tablet candy and preparation method thereof | |
| CN114028514B (en) | Wolfberry fruit medicinal and edible dual-purpose composition with memory improving effect and preparation method and application thereof | |
| CN105497106A (en) | Traditional Chinese medicine compound fermentation powder and preparation method thereof | |
| KR20200087606A (en) | Compositions for Improving Memory Power and Learning Ability, and Relaxing stress | |
| CN103933146A (en) | Pollen product capable of adjusting human body immunity | |
| CN108660174B (en) | Sesame bioactive peptide for resisting fatigue and promoting intestinal probiotic proliferation | |
| CN110679935A (en) | Burdock and ginseng essence cream and preparation method thereof | |
| CN105028854A (en) | Amino acid Maca tablet candy, preparation method and application thereof | |
| KR20210002221A (en) | Red ginseng products containing noni and the process for the preparation thereof | |
| CN108785649B (en) | Composition for controlling weight of pressure type obesity | |
| CN111165797A (en) | Nutritional energy diet suitable for comprehensive regulation of physical functions of astronauts | |
| CN102824369A (en) | Snake gall capsules and preparation method thereof | |
| CN107753752A (en) | A kind of relieving alcoholism and protecting liver stem of noble dendrobium electuary | |
| CN106619876A (en) | Pharmaceutical composition for treating anorexia | |
| CN106490527A (en) | A kind of fig chewable tablets | |
| CN106490599A (en) | A kind of fig anthocyanidin chewable tablets | |
| CN105168954A (en) | Health care composition | |
| CN104971157A (en) | Externally applied powder for treating beriberi and preparation method | |
| KR20170051118A (en) | A barbados aloe scar eliminating ointment | |
| CN103734715A (en) | Fat-reducing conditioning composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |